totally agree with that Mita. However its still a risk until FDA gives its clearance or otherwise. Until then why take this company over. Also depending on SP (and it should rise quickly should the all clear be provided by the FDA) it may suit their purposes better to keep paying the royalties over time rather than stump up the cash up front or obtain funding to take the company over.
the royalties would be rather small in comparison to their turnover.
Add to My Watchlist
What is My Watchlist?
